A randomized, double-blind, placebo-controlled study of the effects of pomegranate extract on rising PSA levels in men following primary therapy for prostate cancer. This article found no significant effect. Read the article.
Pomegranate Extract Not Helpful Read More »
A new BMC Medicine review details a variety of foods, nutrients, and diets that may hold promise for reducing the incidence or progression of prostate cancer (PCa). Not a lot new in this article, but a lot of detail in the actual medical journal article available with a click. Read the article.
Latest Dietary Advice for Prostate Cancer Read More »
In a groundbreaking laboratory study, a research team at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has found that a non-toxic oral agent that is also consumed as an over-the-counter dietary supplement in Europe and Asia for improving liver health, is highly effective in both preventing and treating prostate cancer. Additionally the agent was able to halt the metastatic spread of the disease. “We found that 4-methylumbelliferone (4-MU) was able to block a key signaling pathway that triggers the development, growth and metastasis of prostate cancer,” said the study’s principal investigator Vinata B. Lokeshwar,
Taking vitamin D supplements could slow or even reverse the progression of less aggressive, or low-grade, prostate tumors without the need for surgery or radiation, says Bruce Hollis, Ph.D., who is at the Medical University of South Carolina. Preliminary results from this study indicate that many of the men who received vitamin D showed improvements in their prostate tumors, whereas the tumors in the placebo group either stayed the same or got worse. Also, vitamin D caused dramatic changes in the expression levels of many cell lipids and proteins, particularly those involved in inflammation. “Cancer is associated with inflammation, especially
Vitamin D may keep low-grade prostate cancer from becoming aggressive Read More »
Consumers are always looking for ways to minimize their cancer risk, which is one reason why many turn to over-the-counter vitamin and mineral supplements. But new research finds that while companies promote dietary supplements for their cancer-prevention benefit, some may end up doing more harm than good. Dr. Tim Byers, director for cancer prevention and control at the University of Colorado Cancer Center, conducted a meta-analysis of two decades worth of research — 12 trials that involved more than 300,000 people — and found a number of supplements actually made a person much more likely to develop certain types of
Dietary supplements linked to increased cancer risk Read More »
Cancer Protection A study from the University of California, Riverside found components of pomegranate juice may stop prostate cancer cells from moving, while also weakening the chemical signals that promote this kind of cancer to spread in the first place. And in a separate study, Israeli researchers found pomegranate juice may prevent and destroy breast cancer cells (though it’s hardly the only cancer-fighting food). Stable PSA Levels Prostate cancer patients may also experience lowered levels of a prostate-specific antigen (PSA) when they drink 8 ounces of pomegranate juice each day, found this study from the University of California, Los Angeles.
Pomegranate Health Benefits Read More »
Brisk walking for about three hours a week is enough to help prostate cancer survivors reduce damaging side effects of their treatment, according to a promising study. “Non-vigorous walking for three hours per week seems to improve the fatigue, depression and body weight issues that affect many men post-treatment,” said Siobhan Phillips, lead author from the Northwestern University’s Feinberg School of Medicine. Read the article.
Brisk walking key for prostate cancer survivors Read More »
Listen to and read about an interview with Dr. Levin in which he goes into greater depth on how to discuss prognosis with cancer patients. Read the article.
Discussing Cancer Prognosis Read More »
While waiting for the video of Dr. Michelle Flax’s presentation on March 25, 2015 on the topic ‘The psychology of a cancer diagnosis’, the slides from this presentation can be viewed by clicking on the link below. Dr Flax Slides
Metformin may decrease the risk of biochemical recurrence (BCR) among men treated for prostate cancer (PCa), according to a recent systematic review and meta-analysis. Read the article.
Metformin May Reduce Prostate Cancer Recurrence Risk Read More »